Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Methylation of the 5-AR2 gene may cause resistance to Finasteride in BPH patients.

Long-term high-dose fluconazole can cause reversible hair loss.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Infections during JAK inhibitor treatment for alopecia areata are usually manageable and rarely stop treatment permanently.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Secukinumab treatment may cause HBV reactivation and hair discoloration.

The multi-injection plate is a less painful and more efficient method for treating patchy hair loss.

The combination therapy effectively treats infertility in PCOS without major side effects.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Para-aminobenzoic acid in hair supplements can cause autoimmune hepatitis.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Allopregnanolone changes gene expression in glioblastoma cells.